Federated Hermes
AERI

Federated Hermes’s Aerie Pharmaceuticals AERI Stock Holding History

Federated Hermes’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-802
Closed -$12K – 2333
2022
Q3 		$12K Buy
+802
New +$9.32K ﹤0.01% 1819
2018
Q4 		– Sell
-22
Closed -$1K – 2353
2018
Q3 		$1K Sell
22
-12,547
-100% -$807K ﹤0.01% 2230
2018
Q2 		$849K Buy
+12,569
New +$703K ﹤0.01% 1336
2018
Q1 		– Sell
-9,537
Closed -$570K – 2256
2017
Q4 		$570K Buy
9,537
+3,859
+68% +$234K ﹤0.01% 1355
2017
Q3 		$276K Sell
5,678
-682
-11% -$37.2K ﹤0.01% 1456
2017
Q2 		$334K Buy
6,360
+6,230
+4,792% +$290K ﹤0.01% 1457
2017
Q1 		$6K Sell
130
-4,317
-97% -$193K ﹤0.01% 1910
2016
Q4 		$168K Buy
4,447
+2,090
+89% +$79K ﹤0.01% 1528
2016
Q3 		$89K Buy
+2,357
New +$52K ﹤0.01% 1575

Federated Hermes's AERI Position: Q4 2022 in Review

Federated Hermes sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 802 shares — an estimated $12K sold.

Federated Hermes first reported a position in AERI in Q3 2016 and held it in 9 quarters. The position peaked at $849K in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Federated Hermes reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Federated Hermes sold 802 Aerie Pharmaceuticals shares in Q4 2022, an estimated $12K.
  • Federated Hermes first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 9 quarters.
  • Federated Hermes's Aerie Pharmaceuticals position peaked at $849K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.